These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 19913032

  • 1. Molecular switch in the glucocorticoid receptor: active and passive antagonist conformations.
    Schoch GA, D'Arcy B, Stihle M, Burger D, Bär D, Benz J, Thoma R, Ruf A.
    J Mol Biol; 2010 Jan 22; 395(3):568-77. PubMed ID: 19913032
    [Abstract] [Full Text] [Related]

  • 2. Agonist versus antagonist induce distinct thermodynamic modes of co-factor binding to the glucocorticoid receptor.
    Kroe RR, Baker MA, Brown MP, Farrow NA, Gautschi E, Hopkins JL, LaFrance RR, Kronkaitis A, Freeman D, Thomson D, Nabozny G, Grygon CA, Labadia ME.
    Biophys Chem; 2007 Jul 22; 128(2-3):156-64. PubMed ID: 17466438
    [Abstract] [Full Text] [Related]

  • 3. Structural basis for antagonist-mediated recruitment of nuclear co-repressors by PPARalpha.
    Xu HE, Stanley TB, Montana VG, Lambert MH, Shearer BG, Cobb JE, McKee DD, Galardi CM, Plunket KD, Nolte RT, Parks DJ, Moore JT, Kliewer SA, Willson TM, Stimmel JB.
    Nature; 2002 Feb 14; 415(6873):813-7. PubMed ID: 11845213
    [Abstract] [Full Text] [Related]

  • 4. Conformational changes of the glucocorticoid receptor ligand binding domain induced by ligand and cofactor binding, and the location of cofactor binding sites determined by hydrogen/deuterium exchange mass spectrometry.
    Frego L, Davidson W.
    Protein Sci; 2006 Apr 14; 15(4):722-30. PubMed ID: 16600964
    [Abstract] [Full Text] [Related]

  • 5. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735.
    Stevens A, Garside H, Berry A, Waters C, White A, Ray D.
    Mol Endocrinol; 2003 May 14; 17(5):845-59. PubMed ID: 12569182
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Exploring the molecular basis of action of the passive antiglucocorticoid 21-hydroxy-6,19-epoxyprogesterone.
    Alvarez LD, Martí MA, Veleiro AS, Presman DM, Estrin DA, Pecci A, Burton G.
    J Med Chem; 2008 Mar 13; 51(5):1352-60. PubMed ID: 18284186
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Differential effects of the new glucocorticoid receptor antagonist ORG 34517 and RU486 (mifepristone) on glucocorticoid receptor nuclear translocation in the AtT20 cell line.
    Peeters BW, Ruigt GS, Craighead M, Kitchener P.
    Ann N Y Acad Sci; 2008 Dec 13; 1148():536-41. PubMed ID: 19120154
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Atomic structure of progesterone complexed with its receptor.
    Williams SP, Sigler PB.
    Nature; 1998 May 28; 393(6683):392-6. PubMed ID: 9620806
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Spectroscopic determination of the binding affinity of zinc to the DNA-binding domains of nuclear hormone receptors.
    Payne JC, Rous BW, Tenderholt AL, Godwin HA.
    Biochemistry; 2003 Dec 09; 42(48):14214-24. PubMed ID: 14640689
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.